STERIS plc
NYSE:STE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
197.5601
246.521
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
STERIS plc
Wall Street
Price Targets
STE Price Targets Summary
STERIS plc
According to Wall Street analysts, the average 1-year price target for
STE
is 257.06 USD
with a low forecast of 232.3 USD and a high forecast of 278.25 USD.
STE Last Price Targets
STERIS plc
The latest public price target was made on Oct 24, 2024 by
Jason Bednar
from
Piper Sandler
,
who expects
STE
stock to
rise by 26%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Jason Bednar
Piper Sandler
|
260
USD
Upside 26% |
2 months ago
Oct 24, 2024
|
Piper Sandler Upgrades STERIS (STE) to Overweight
StreetInsider
|
Brett Fishbin
KeyBanc
|
265
USD
Upside 29% |
4 months ago
Sep 3, 2024
|
Steris price target raised to $265 from $255 at KeyBanc
TheFly
|
|
Jason Bednar
Piper Sandler
|
225
USD
Upside 9% |
8 months ago
May 10, 2024
|
STERIS (STE) PT Raised to $225 at Piper Sandler
StreetInsider
|
Mike Polark
Wolfe Research
|
245
USD
Upside 19% |
9 months ago
Apr 4, 2024
|
STERIS (STE) PT Raised to $245 at Wolfe Research
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is STE's stock price target?
Price Target
257.06
USD
According to Wall Street analysts, the average 1-year price target for
STE
is 257.06 USD
with a low forecast of 232.3 USD and a high forecast of 278.25 USD.
What is STERIS plc's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
STERIS plc's revenue is
11%.
The projected
CAGR
for the next 3 years is
7%.
What is STERIS plc's Operating Income forecast?
Projected CAGR
18%
For the last 8 years the
compound annual growth rate for
STERIS plc's operating income is
20%.
The projected
CAGR
for the next 3 years is
18%.
What is STERIS plc's Net Income forecast?
Projected CAGR
41%
For the last 8 years the
compound annual growth rate for
STERIS plc's net income is
17%.
The projected
CAGR
for the next 3 years is
41%.
You don't have any saved screeners yet
